Shigeshi Kamikawa

712 total citations
34 papers, 501 citations indexed

About

Shigeshi Kamikawa is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Shigeshi Kamikawa has authored 34 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Shigeshi Kamikawa's work include Atrial Fibrillation Management and Outcomes (15 papers), Cardiac Arrhythmias and Treatments (13 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Shigeshi Kamikawa is often cited by papers focused on Atrial Fibrillation Management and Outcomes (15 papers), Cardiac Arrhythmias and Treatments (13 papers) and Cardiac electrophysiology and arrhythmias (9 papers). Shigeshi Kamikawa collaborates with scholars based in Japan and United States. Shigeshi Kamikawa's co-authors include Shozo Kusachi, Satoshi Hirohata, Toru Miyoshi, Masayuki Doi, Masaaki Murakami, Kazuyoshi Hina, Takashi Murakami, Yoshifumi Ninomiya, Hirosuke Yamaji and Tomoki Kitawaki and has published in prestigious journals such as Clinica Chimica Acta, The American Journal of the Medical Sciences and International Journal of Cardiology.

In The Last Decade

Shigeshi Kamikawa

33 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeshi Kamikawa Japan 13 413 138 92 47 42 34 501
Sung-Won Jang South Korea 11 311 0.8× 96 0.7× 57 0.6× 42 0.9× 41 1.0× 47 501
Bülent Behlül Altunkeser Türkiye 13 255 0.6× 85 0.6× 80 0.9× 57 1.2× 34 0.8× 43 374
Chan Joon Kim South Korea 11 191 0.5× 133 1.0× 72 0.8× 50 1.1× 26 0.6× 46 337
Takashi Sugamori Japan 12 328 0.8× 79 0.6× 79 0.9× 56 1.2× 34 0.8× 35 462
Habil Yücel Türkiye 12 278 0.7× 63 0.5× 59 0.6× 38 0.8× 38 0.9× 29 404
Martin Poloczek Czechia 11 278 0.7× 155 1.1× 84 0.9× 45 1.0× 20 0.5× 43 375
Dexi Wu China 15 531 1.3× 164 1.2× 36 0.4× 30 0.6× 75 1.8× 27 645
Kazuyoshi Hina Japan 12 583 1.4× 213 1.5× 221 2.4× 65 1.4× 85 2.0× 42 755
Hyemoon Chung South Korea 12 295 0.7× 91 0.7× 86 0.9× 40 0.9× 57 1.4× 53 394
J.‐C. Tardif Canada 11 318 0.8× 197 1.4× 56 0.6× 66 1.4× 43 1.0× 24 493

Countries citing papers authored by Shigeshi Kamikawa

Since Specialization
Citations

This map shows the geographic impact of Shigeshi Kamikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeshi Kamikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeshi Kamikawa more than expected).

Fields of papers citing papers by Shigeshi Kamikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeshi Kamikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeshi Kamikawa. The network helps show where Shigeshi Kamikawa may publish in the future.

Co-authorship network of co-authors of Shigeshi Kamikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeshi Kamikawa. A scholar is included among the top collaborators of Shigeshi Kamikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeshi Kamikawa. Shigeshi Kamikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamaji, Hirosuke, Takashi Murakami, Hiroshi Kawamura, et al.. (2022). Optimal prevention method of phrenic nerve injury in superior vena cava isolation: efficacy of high-power, short-duration radiofrequency energy application on the risk points. Journal of Interventional Cardiac Electrophysiology. 66(6). 1465–1475. 8 indexed citations
3.
Yamaji, Hirosuke, Takashi Murakami, Hiroshi Kawamura, et al.. (2021). Rates of atrial flutter occurrence and cavotricuspid isthmus reconduction after prophylactic isthmus ablation performed during atrial fibrillation ablation: a clinical study, review, and comparison with previous findings. Journal of Interventional Cardiac Electrophysiology. 64(1). 67–76. 2 indexed citations
4.
Yamaji, Hirosuke, Takashi Murakami, Kazuyoshi Hina, et al.. (2020). Efficacy of an Adjunctive Electrophysiological Test–Guided Left Atrial Posterior Wall Isolation in Persistent Atrial Fibrillation Without a Left Atrial Low-Voltage Area. Circulation Arrhythmia and Electrophysiology. 13(8). e008191–e008191. 16 indexed citations
5.
6.
Yamaji, Hirosuke, Takashi Murakami, Kazuyoshi Hina, et al.. (2018). Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation. Heart and Vessels. 34(2). 331–342. 9 indexed citations
7.
Yamaji, Hirosuke, Takashi Murakami, Kazuyoshi Hina, et al.. (2018). Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin. Journal of Cardiovascular Electrophysiology. 29(6). 835–843. 9 indexed citations
8.
Yamaji, Hirosuke, Takashi Murakami, Kazuyoshi Hina, et al.. (2017). Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence. Open Heart. 4(1). e000593–e000593. 4 indexed citations
9.
Yamaji, Hirosuke, Takashi Murakami, Kazuyoshi Hina, et al.. (2016). Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Clinical Drug Investigation. 36(10). 837–848. 22 indexed citations
10.
11.
Yamaji, Hirosuke, Takashi Murakami, Kazuyoshi Hina, et al.. (2013). Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation. Clinical Drug Investigation. 33(6). 409–418. 42 indexed citations
12.
Miyoshi, Toru, Masayuki Doi, Satoshi Hirohata, et al.. (2010). Cardio-Ankle Vascular Index is Independently Associated with the Severity of Coronary Atherosclerosis and Left Ventricular Function in Patients with Ischemic Heart Disease. Journal of Atherosclerosis and Thrombosis. 17(3). 249–258. 82 indexed citations
13.
Miyoshi, Toru, Masayuki Doi, Satoshi Hirohata, et al.. (2010). Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients. Heart and Vessels. 26(4). 408–413. 55 indexed citations
14.
Doi, Masayuki, Toru Miyoshi, Satoshi Hirohata, et al.. (2010). Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients. The American Journal of the Medical Sciences. 339(5). 433–439. 19 indexed citations
15.
Miyoshi, Toru, Masayuki Doi, Satoshi Hirohata, et al.. (2009). Augmentation index is associated with B-type natriuretic peptide in patients with paroxysmal atrial fibrillation. Hypertension Research. 32(7). 611–616. 19 indexed citations
16.
Doi, Masayuki, Toru Miyoshi, Satoshi Hirohata, et al.. (2008). Increased Augmentation Index of the Radial Pressure Waveform in Patients with Paroxysmal Atrial Fibrillation. Cardiology. 113(2). 138–145. 12 indexed citations
17.
Iwasaki, Katsurô, Keizô Yamamoto, Shozo Kusachi, et al.. (2006). Coronary pressure measurement to identify the lesion requiring percutaneous coronary intervention in equivocal tandem lesions. Coronary Artery Disease. 17(2). 181–186. 13 indexed citations
18.
Murakami, Masaaki, Katsurô Iwasaki, Shozo Kusachi, et al.. (2005). Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting. International Journal of Cardiology. 107(1). 48–53. 25 indexed citations
19.
Iwasaki, Katsurô, Keizô Yamamoto, Shozo Kusachi, et al.. (2005). Coronary pressure measurement to determine treatment strategy for equivocal left main coronary artery lesions. Heart and Vessels. 20(6). 271–277. 25 indexed citations
20.
Kamikawa, Shigeshi, Katsurô Iwasaki, Keizô Yamamoto, et al.. (2005). Significant correlation of recruitable coronary collateral blood flow determined by coronary wedge pressure with ST-segment elevation during coronary occlusion. Coronary Artery Disease. 16(4). 231–236. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung-Won Jang Breakdown of academic impact, for papers by Bülent Behlül Altunkeser Breakdown of academic impact, for papers by Chan Joon Kim Breakdown of academic impact, for papers by Takashi Sugamori Breakdown of academic impact, for papers by Habil Yücel Breakdown of academic impact, for papers by Martin Poloczek Breakdown of academic impact, for papers by Dexi Wu Breakdown of academic impact, for papers by Kazuyoshi Hina Breakdown of academic impact, for papers by Hyemoon Chung Breakdown of academic impact, for papers by J.‐C. Tardif
Rankless by CCL
2026